NCT04494113 2026-03-18Testing the Response to the Anti-cancer Drug, Triapine, in Uterine Cancers Using Markers From the Tissue at the Time of HysterectomyNational Cancer Institute (NCI)Phase EARLY_PHASE1 Active not recruiting12 enrolled